Clinical Trials on Høj risiko ulmende myelomatose in United States
I alt 2374 resultater
-
Irene Ghobrial, MDJanssen Research & Development, LLCRekrutteringMyelomatose | Ulmende myelomatose | Højrisiko ulmende myelomatoseForenede Stater
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.AfsluttetHøj risiko ulmende myelomatoseForenede Stater
-
Omar Nadeem, MDJanssen, LPRekruttering
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.AfsluttetMyelomatose | Høj risiko ulmende myelomatoseForenede Stater
-
Janssen Research & Development, LLCAfsluttetHøjrisiko ulmende myelomatoseForenede Stater, Det Forenede Kongerige, Belgien, Tyskland, Frankrig, Spanien, Korea, Republikken, Australien, Israel, Grækenland, Sverige
-
National Cancer Institute (NCI)AfsluttetMyelom, multipel | Myelom-multipelForenede Stater
-
Michael A. Thompson, MD, PhDVince Lombardi Cancer ClinicAfsluttetMyelomatose | Myelom, multipel | Myelom-multipelForenede Stater
-
US Oncology ResearchKaryopharm Therapeutics IncRekrutteringMyelomatose | Plasmacellemyelom | Myelom-multipel | Myelom multipel | Kahlers sygdom | Myelom, plasmacelle | MyelomatoseForenede Stater
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncAfsluttetRefraktær Myelom | Myelom | Myelom multipelForenede Stater
-
University College, LondonCancer Research UKRekrutteringMyelomatose | MGUS | Ulmende myelomDet Forenede Kongerige
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeMyelom-multipel | Myelom, plasmacelleForenede Stater
-
National Cancer Institute (NCI)AfsluttetMyelom-multipel | Myelom, plasmacelleForenede Stater
-
National Cancer Institute (NCI)AfsluttetMyelom-multipel | Myelom, plasmacelleForenede Stater
-
Benovus Bio, Inc.UkendtMyelodysplastisk syndrom (MDS) | Akut myelogen leukæmi (AML) | Myelomatose (MM) | Ulmende myelomatose (sMM)Forenede Stater
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RekrutteringUlmende plasmacellemyelomForenede Stater
-
M.D. Anderson Cancer CenterAktiv, ikke rekrutterendeUlmende plasmacellemyelomForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Trukket tilbageUlmende plasmacellemyelomForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeUlmende plasmacellemyelomForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeUlmende plasmacellemyelomForenede Stater
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRekrutteringNavlestrengsblodtransplantation | Højrisiko Myeloid MaligniteterForenede Stater
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthAfsluttetMyelom-multipel | Myelom, plasmacelle | MyelomatoseForenede Stater
-
Carl Ola Landgren, MD, PhDJanssen Scientific Affairs, LLCRekruttering
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeUlmende plasmacellemyelomForenede Stater
-
University of Colorado, DenverAfsluttetPlasmacellemyelom | Tilbagevendende plasmacellemyelom | Ulmende plasmacellemyelom | PlasmacytoseForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutteringUlmende plasmacellemyelomForenede Stater
-
University of UtahMillennium Pharmaceuticals, Inc.AfsluttetKræft | Myelomatose | MyelomForenede Stater
-
Memorial Sloan Kettering Cancer CenterHealthTree FoundationRekrutteringMyelom, ulmendeForenede Stater
-
Case Comprehensive Cancer CenterTrukket tilbageMyelom | Ulmende myelom | Monoklonal gammopatiForenede Stater
-
National Cancer Institute (NCI)AfsluttetMonoklonal gammopati af ubestemt betydning | Ulmende myelomForenede Stater
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple... og andre samarbejdspartnereAfsluttetE-PRISM: Fase II-forsøg med Elotuzumab Lenalidomid og Dexamethason ved højrisiko-ulmende myelomatoseUlmende myelomatose | Ulmende myelomForenede Stater
-
Mayo ClinicNational Cancer Institute (NCI)AfsluttetPlasmacellemyelom | Ulmende plasmacellemyelom | Indolent plasmacellemyelomForenede Stater
-
Mayo ClinicAktiv, ikke rekrutterendePlasmacellemyelom | Refraktært plasmacellemyelom | Tilbagevendende plasmacellemyelom | Ulmende plasmacellemyelomForenede Stater
-
Cartesian TherapeuticsRekrutteringMyelom multipelForenede Stater
-
City of Hope Medical CenterAfsluttetStadie I Myelom | Stadie II Myelom | Stadium III Myelom | Ulmende myelomatose | Refraktær MyelomForenede Stater
-
Oxford University Hospitals NHS TrustAmgenAfsluttetMyelom | Ulmende myelom | Monoklonal gammopati af ubestemt betydning (MGUS)Det Forenede Kongerige
-
Roswell Park Cancer InstituteRekrutteringPlasmacellemyelom | Refraktært plasmacellemyelom | Tilbagevendende plasmacellemyelom | Ulmende plasmacellemyelomForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringMonoklonal gammopati af ubestemt betydning | Ulmende plasmacellemyelomForenede Stater
-
Cartesian TherapeuticsAfsluttetMyelom multipelForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringMonoklonal gammopati af ubestemt betydning | Ulmende plasmacellemyelomForenede Stater
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RekrutteringUlmende plasmacellemyelomForenede Stater
-
K36 Therapeutics, Inc.RekrutteringMyelomatose | Myelom | Myelom multipelForenede Stater, Frankrig, Spanien, Canada
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKTrukket tilbageMyelom multipelDet Forenede Kongerige
-
M.D. Anderson Cancer CenterRekruttering
-
CASI Pharmaceuticals, Inc.AfsluttetRecidiverende myelomatose | Plateaufase multipelt myelomForenede Stater
-
New York City Health and Hospitals CorporationNew York State Department of HealthAfsluttetHøjrisikobrugere med høje omkostninger Medicaid ServicesForenede Stater
-
NYU Langone HealthUnicorn Pacific CorporationAfsluttetMyelomForenede Stater
-
University of ArkansasMillennium Pharmaceuticals, Inc.AfsluttetAsymptomatic Multiple MyelomaForenede Stater
-
Indiana UniversityAfsluttetGraviditet, høj risikoForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeHæmatopoietisk og lymfoid celle-neoplasma | Tilbagevendende Hodgkin-lymfom | Myelodysplastisk syndrom | Tilbagevendende akut myeloid leukæmi | Tilbagevendende myelodysplastisk syndrom | Højrisiko Myelodysplastisk Syndrom | Tilbagevendende non-Hodgkin-lymfom | Tilbagevendende akut lymfatisk leukæmi | Tilbagevendende... og andre forholdForenede Stater
-
Yale UniversityAfsluttetAsymptomatisk myelomForenede Stater